搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Corynebacterium glutamicum Alanine--tRNA ligase (alaS), partial CSB-YP850945DWY
CSB-EP850945DWY
CSB-BP850945DWY
CSB-MP850945DWY
CSB-EP850945DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Peptide deformylase 1 (def1) CSB-YP850946DWY
CSB-EP850946DWY
CSB-BP850946DWY
CSB-MP850946DWY
CSB-EP850946DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum UPF0237 protein Cgl1544/cg1742 (Cgl1544, cg1742) CSB-YP850947DWY
CSB-EP850947DWY
CSB-BP850947DWY
CSB-MP850947DWY
CSB-EP850947DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum AAA ATPase forming ring-shaped complexes (arc), partial CSB-YP850948DWY
CSB-EP850948DWY
CSB-BP850948DWY
CSB-MP850948DWY
CSB-EP850948DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum UPF0225 protein Cgl1438/cg1626 (Cgl1438, cg1626) CSB-YP850949DWY
CSB-EP850949DWY
CSB-BP850949DWY
CSB-MP850949DWY
CSB-EP850949DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Tyrosine--tRNA ligase (tyrS) CSB-YP850950DWY
CSB-EP850950DWY
CSB-BP850950DWY
CSB-MP850950DWY
CSB-EP850950DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum D-alanine--D-alanine ligase (ddl) CSB-YP850951DWY
CSB-EP850951DWY
CSB-BP850951DWY
CSB-MP850951DWY
CSB-EP850951DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Ribose import ATP-binding protein RbsA (rbsA), partial CSB-YP850952DWY
CSB-EP850952DWY
CSB-BP850952DWY
CSB-MP850952DWY
CSB-EP850952DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Aliphatic sulfonates import ATP-binding protein SsuB (ssuB) CSB-YP850953DWY
CSB-EP850953DWY
CSB-BP850953DWY
CSB-MP850953DWY
CSB-EP850953DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Sec-independent protein translocase protein TatB (tatB), partial CSB-YP850954DWY
CSB-EP850954DWY
CSB-BP850954DWY
CSB-MP850954DWY
CSB-EP850954DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Quinolinate synthase A (nadA) CSB-YP850955DWY
CSB-EP850955DWY
CSB-BP850955DWY
CSB-MP850955DWY
CSB-EP850955DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum HTH-type transcriptional repressor of iron proteins A (ripA) CSB-YP850956DWY
CSB-EP850956DWY
CSB-BP850956DWY
CSB-MP850956DWY
CSB-EP850956DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Methionine--tRNA ligase (metG), partial CSB-YP850957DWY
CSB-EP850957DWY
CSB-BP850957DWY
CSB-MP850957DWY
CSB-EP850957DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum 30S ribosomal protein S14 (rpsN) CSB-YP850958DWY
CSB-EP850958DWY
CSB-BP850958DWY
CSB-MP850958DWY
CSB-EP850958DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Histidinol-phosphatase (hisN) CSB-YP850959DWY
CSB-EP850959DWY
CSB-BP850959DWY
CSB-MP850959DWY
CSB-EP850959DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Probable methylisocitrate lyase 1 (prpB1) CSB-YP850960DWY
CSB-EP850960DWY
CSB-BP850960DWY
CSB-MP850960DWY
CSB-EP850960DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum 10 kDa chaperonin (groS) CSB-YP850961DWY
CSB-EP850961DWY
CSB-BP850961DWY
CSB-MP850961DWY
CSB-EP850961DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum 30S ribosomal protein S11 (rpsK) CSB-YP850962DWY
CSB-EP850962DWY
CSB-BP850962DWY
CSB-MP850962DWY
CSB-EP850962DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum 30S ribosomal protein S8 (rpsH) CSB-YP850963DWY
CSB-EP850963DWY
CSB-BP850963DWY
CSB-MP850963DWY
CSB-EP850963DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum 50S ribosomal protein L2 (rplB) CSB-YP850964DWY
CSB-EP850964DWY
CSB-BP850964DWY
CSB-MP850964DWY
CSB-EP850964DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>